GlobeNewswire
Agomab Announces Closing of Initial Public Offering
📈
AI Sentiment
Highly Positive
8/10
- Home
- AGMB
AGMB
AgomAb Therapeutics NV American Depositary Shares
as of 02-11-2026 4:00pm EST
$16.00
+$0.45
+2.89%
| Founded: | 2017 | Country: | Belgium |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2026 |
| Target Price: | N/A | AVG Volume (30 days): | 931.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3391.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.66 - $16.05 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -61225316.0 | FCF Growth: | N/A |
Latest AgomAb Therapeutics NV American Depositary Shares News
AGMB Breaking Stock News: Dive into AGMB Ticker-Specific Updates for Smart Investing
Compare AGMB vs Leading Stocks
See how AGMB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AGMB AgomAb Therapeutics NV American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.